What Is Multiple Myeloma?

Multiple myeloma is a type of blood cancer that starts in the plasma cells, which are found in the bone marrow. These cells normally help your body fight infection. But in myeloma, they grow uncontrollably, pushing out healthy cells.

Common signs of multiple myeloma include:

• Ongoing bone pain
• Feeling tired all the time
• Getting sick often
• Weak kidneys or low blood counts

At OncoCare, our myeloma specialists in Singapore use modern diagnostic tools such as bone marrow biopsy, blood tests, and scans to confirm the diagnosis and understand how advanced the disease is.

How Is Multiple Myeloma Usually Treated?

Traditionally, myeloma is treated with:

• Chemotherapy
• Targeted therapy
• Stem cell transplants
• Immunotherapy drugs

While these treatments can be effective, they don’t always work the same way for everyone. That’s because myeloma behaves differently in each person.

What Is Precision Medicine?

At OncoCare, we believe in using precision medicine for myeloma — a personalised approach to cancer treatment. Instead of giving the same treatment to every patient, we tailor your care based on the genetic makeup of your cancer.

This means:

• Studying the DNA of the cancer cells
• Finding specific mutations or markers
• Matching you with targeted therapies that work best for your unique case

This is also called personalised cancer care, and it’s a big step forward in improving outcomes and reducing side effects.

How Precision Medicine Targets Myeloma

Using advanced testing and genomic profiling, our oncologists can identify what’s driving your cancer and choose treatments that target those weak points.

Here’s how some of these modern therapies work:

Proteasome Inhibitors (e.g., Bortezomib)

These drugs block the cancer cells’ waste removal system, which causes them to shut down and die.

Monoclonal Antibodies (e.g., Daratumumab)

These special antibodies attach to myeloma cells and help your immune system find and destroy them.

CAR T-cell Therapy

A highly advanced treatment where your immune cells are reprogrammed in a lab to attack cancer more effectively. This is often used when other treatments stop working.

Newer Immunotherapies: BiTE Agents (e.g., Teclistamabm, Talquetamab)

Innovative options like Teclistamab and Talquetamab are BiTE (bispecific T-cell engager) therapies — designed to bring immune cells directly to cancer cells, helping the body fight back more precisely.

Targeted Therapy (e.g., Venetoclax)

Some drugs are designed to work only if you have certain gene changes, which is why genetic testing is so important.

Why Patients in Singapore Choose Precision Medicine at OncoCare

Here’s how precision medicine at OncoCare benefits patients with multiple myeloma:

More accurate treatments, based on your cancer’s genetics
Fewer side effects, since the treatments are more targeted
Better long-term results, especially for patients with relapsed or hard-to-treat myeloma

We also continue to monitor how your cancer responds and adjust your treatment over time.

Personalised Myeloma Treatment in Singapore at OncoCare

At OncoCare Medical, our cancer specialists work with top diagnostic labs to uncover the genetic fingerprint of your cancer. This gives us vital information to personalise your treatment and help you feel more confident about your care.

We are proud to offer:

• Expert myeloma doctors in Singapore
• Access to cutting-edge diagnostics
• A patient-first approach that focuses on your unique needs

Book Your Myeloma Consultation Today

If you or a loved one is looking for multiple myeloma treatment in Singapore, or if you want to explore precision medicine options, we’re here to help.

Contact OncoCare today to book an appointment with a myeloma specialist in Singapore and take the first step toward a treatment plan designed just for you.

“Expert knowledge means better care for cancer.”

Contributed by:

Dr Kevin Tay

MBBS (Singapore)
ABIM Int. Med (USA)
ABIM Med Onc (USA)
FAMS (Medical Oncology)